ArticleFrontiers in genetics2022

A novel transcription factor-based signature to predict prognosis and therapeutic response of hepatocellular carcinoma.

Yanbing Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.